Funding for this research was provided by:
Merck Sharp and Dohme
University of Texas MD Anderson Cancer Center
Text and Data Mining valid from 2018-05-30
Received: 14 February 2018
Accepted: 6 May 2018
First Online: 30 May 2018
Ethics approval and consent to participate
: This clinical trial (NCT00769483) was approved by the MD Anderson Institutional Review Board, and all study participants signed an informed consent.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.